ATLASATLAS fair value
ATLAS has no fair value for this stock today.
MDxHealth SA (MDXH)
MDxHealth SA stock price today, ATLAS forecast and fair value
Healthcare · Diagnostics & Research · NASDAQ
$0.18▼ -7.56%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
39%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on MDxHealth SA in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On MDxHealth SA
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives MDxHealth SA a 39% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $0.12 and $0.22; in 9 out of 10, between $0.07 and $0.37. Estimated annual volatility is 200%.
Key numbers
- Revenue (12 months)
- $114M
- Revenue growth (YoY)
- +19.8%
- Gross margin
- 64.6%
- Operating margin
- -14.2%
- Net margin
- -31.1%
- Return on equity
- 277.2%
- Free cash flow (12 months)
- $-17.4M
- Beta
- -501,643.70
What this means
ATLAS does not publish a fair value for MDXH right now, but it does show its odds of rising: somewhat worse than a coin flip.
On the business: revenue grew 19.8% year over year; net margin is 31.1%.
Its beta is -501,643.70: it tends to move less than the market.
About the company
MDxHealth SA is a commercial-stage precision diagnostics company focused on molecular testing for urologic diseases.
Want to see everything about MDxHealth SA?
Get started →Plans from €3.99 a month.
Frequently asked questions
What does MDxHealth SA do?
MDxHealth SA is a commercial-stage precision diagnostics company focused on molecular testing for urologic diseases.
What is the chance MDXH goes up next month?
39%: somewhat worse than a coin flip. In half of the simulated outcomes, MDXH ends the month between $0.12 and $0.22.
How volatile is MDXH?
ATLAS estimates annual volatility at 200%. In a typical month, half of the outcomes end between $0.12 and $0.22.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer